Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01314118
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Conditions: Prostate Cancer;   Prostatic Neoplasm
Intervention: Drug: abiraterone acetate in combination with prednisone

Indicates status has not been verified in more than two years